The Pediatric Oncology Division of the University of British Columbia, Department of Pediatrics, has a long established record of commitment to CCG. The Division has enjoyed full membership since 1974 and NCI funding support since 1980. The Division actively participates in CCG Trials as well as being involved in strategic planning, trial design, lab-based research, outcome analysis and administrative responsibilities within the CCG network. During the next 5 year grant cycle, the Division will continue to participate in all aspects of CCG activities.
Specific aims : Commitment to continue to enter as many patients as possible into CCG Trials; Actively participate in new proposals specifically in the field of high risk acute lymphatic leukemia (Dr. K. Schultz), Hodgkin's Disease (Dr. C. Fryer), radionucleotide imaging studies- Thallium (Dr. H. Nadel), radiotherapy aspects of CCG (Dr. C. Fryer); Investigate prognostic markers specifically the significance of molecular abnormalities in sarcomas (Dr. P. Sorensen); Continue to develop new therapies for poor prognostic patients, specifically to continue Phase II Pilot work on marrow ablative therapy and PBSC rescue in patients presenting with metastatic disease utilizing molecular genetic techniques to detect minimal residual disease and contamination of PBSC; To continue our laboratory research into understanding mechanisms of graft-versus-host disease and graft-versus-leukemia effect to gain further understanding of the host response to malignant disease; To expand our molecular biology research into the genetic changes associated with childhood cancers; and to investigate the cytolytic T-cell therapy for Hodgkin's Disease directed against EB viral antigens (Dr. K. Schultz and Dr. Ru Tan).

National Institute of Health (NIH)
National Cancer Institute (NCI)
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Smith, Malcolm M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of British Columbia
Zip Code
V6 1-Z3
Neudorf, Steven; Sanders, Jean; Kobrinsky, Nathan et al. (2004) Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood 103:3655-61
Seitzman, Robin L; Glover, Dorie A; Meadows, Anna T et al. (2004) Self-concept in adult survivors of childhood acute lymphoblastic leukemia: a cooperative Children's Cancer Group and National Institutes of Health study. Pediatr Blood Cancer 42:230-40
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Davies, Stella M; Bhatia, Smita; Ross, Julie A et al. (2002) Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Cairo, M S; Krailo, M D; Morse, M et al. (2002) Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia 16:594-600
Wells, R J; Arthur, D C; Srivastava, A et al. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 16:601-7
Cooper, R; Khakoo, Y; Matthay, K K et al. (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med Pediatr Oncol 36:623-9
Kammen, B F; Matthay, K K; Pacharn, P et al. (2001) Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol 176:755-9

Showing the most recent 10 out of 11 publications